Retractable Technologies, Inc. (RVP)
| Market Cap | 530.92M |
| Revenue (ttm) | 62.50M |
| Net Income (ttm) | 16.43M |
| Shares Out | 33.37M |
| EPS (ttm) | 0.50 |
| PE Ratio | 31.40 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $15.70 |
| Previous Close | $15.56 |
| Change ($) | 0.14 |
| Change (%) | 0.90% |
| Day's Open | 15.56 |
| Day's Range | 14.85 - 16.05 |
| Day's Volume | 413,802 |
| 52-Week Range | 0.97 - 21.50 |
These are the small-cap stocks with the best value, fastest growth, and most momentum for March 2021.
Retractable Technologies saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 94 the day before. The post Retractable Technologies Receives IBD Stock Rating Upgrade appeared f...
He's a stickler for predictable and recurring revenue.
Investing in the recovery from the pandemic could pay off big.
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B an...
These companies made millions by developing equipment for life-saving care, and enriched shareholders too.
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
Sales jumped 132% in the most recent quarter, as demand for the company's syringes have skyrocketed.
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $10.3 million in the third quarter of 2020, compared to an operati...
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B an...
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $960 thousand in the second quarter of 2020, compared to an operat...
The company's been awarded a multimillion-dollar government COVID-19 contract to expand production of needles and syringes.
Retractable Technologies Inc. reported Q1 earnings highlighted by strong sales growth and firming profitability.
Retractable Technologies (NYSE: RVP) shares are trading higher on Monday, after a report the company has won a government contract for $84 million.
About RVP
Retractable Technologies designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, autodisable, and allergy antigen syringes; IV catheters; blood collection tube holders; blood collection sets; and Patient Safe safety medical products, including syringes and Luer caps. The company also engages in developing retractable needles and s... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date May 4, 2001 |
| CEO Thomas J. Shaw | Employees 135 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol RVP |